AI-enabled Chest X-ray reporting for Health System Strengthening
MLC Vanguard | Created by Qure.ai
qXR, a CE MDR Class IIb certified and WHO-evaluated AI tool, detects over 35 lung abnormalities, including TB and lung cancer, in under a minute. This accelerates diagnosis, optimizes resources, and improves patient outcomes, enhancing integrated healthcare delivery in resource-limited settings.
2,213,273 Lives Impacted
Qure is deployed at 2,658 sites across 90 countries, impacting over 20 million lives. Our AI solutions are highly adaptable, functioning across diverse settings regardless of geography, internet availability, or hardware type. Qure has screened around 15 million people for identifying lung findings on Chest X-rays globally, bringing AI-powered diagnostics to the world's most remote regions. These figures reflect countless individual stories—families and communities now imbued with hope and health through our partners' collective efforts. Deploying AI in areas lacking internet or electricity challenges us to innovate in product development and operationalization. We have alerted over 400,000 individuals for early signs of Tuberculosis and Lung Cancer, underscoring our commitment to making a significant impact where it matters most.
The Innovation
qXR is transforming traditional healthcare practices by leveraging advanced AI technology to enhance chest X-ray interpretation with exceptional accuracy and efficiency. Trained on over 5 million CXRs, qXR offers rapid and precise interpretations, facilitating quicker diagnostic and treatment decisions. This efficiency is vital in managing large patient volumes, especially in under-resourced settings characterised by substantial capacity and infrastructure deficits. By detecting a wide array of lung abnormalities, including TB, pneumonia, lung cancer, and COPD, qXR ensures comprehensive lung health screening. Its hardware independence and interoperability allow for deployment in diverse healthcare environments, from urban centers to remote, resource-limited areas. Additionally, integration with the Qure app, a workflow management platform, bolsters health systems by supporting integrated disease management. This combination enhances coordinated care pathways and improves patient outcomes by minimizing loss to follow-up.
Implemented in
Qure solutions are deployed in 90+ countries including Argentina, Australia, Bosnia and Herzegovina, Brazil, Bulgaria, Cambodia, Central African Republic, Chile, Colombia, Costa Rica, Cuba, Czech Republic, DR Congo, Ecuador, Egypt, Ethiopia, Fiji, France, Germany, Guatemala, Guinea-Bissau, Haiti, India, Indonesia, Iraq, Jordan, Kenya, Lebanon, Lesotho, Liberia, Malawi, Malaysia, Mozambique, Myanmar, Namibia, Nigeria, Pakistan, Panama, Papua New Guinea, Peru, Philippines, Saudi Arabia, Sierra Leone, Singapore, Somalia, South Africa, South Sudan, Spain, Sweden, Tajikistan, Thailand, Timor-Leste, Turkey, Uganda, United Arab Emirates, United Kingdom, United States, Vietnam, Zambia, Zimbabwe.
Get in touch
Sanya Chawla, Director — Global Health Innovation sanya.chawla@qure.ai
Enla Fees, Director of Global Health — Stakeholder Engagement
Enla.Fees@qure.ai
About qure.ai
Qure.ai is a breakthrough Artificial Intelligence solution provider for AI-powered integrated healthcare delivery. Qure.ai solutions provide automated interpretation of radiology exams like X-rays, and CT scans for resource-strapped settings- enabling faster diagnosis and early access to treatment for TB, lung cancer, stroke, and other diseases.
